September 2025 – Clinical Trial Results

Dr. Lakdawala, Dr. Januzzi and Dr. C. Michael Gibson discuss the findings were presented at HFSA from the phase 2a clinical trial of danicamtiv in patients with genetic DCM

September 29, 2025

Disclosures: TBD

Dr. Hofmann and Dr. Gibson discuss HELP-MI SWEDEHEART trial

September 5, 2025

Disclosures: TBD

Dr. Maros Ferencik and Dr. C. Michael Gibson discuss: Clinical Utility of Atherosclerosis Imaging in Symptomatic Patients: Lessons Learned from CCTA

September 4, 2025

Sponsored by Cleerly, Women as One, and International Atherosclerosis Society

Dr. Renato Lopes and Dr. C. Michael Gibson discuss the results of the PARCUTE-HF trial testing the benefits of 2 drugs in a big but neglected population, those patients with Chagas Disease and Heart Failure

September 1, 2025

Disclosures: TBD